Article type
Year
Abstract
Background: The quality of health systems is measured and influenced by limiting factors such as access, timeliness, coverage and equity in service to the population. France is known for its good health system, as the country spent 4056 (USD) per year per person on health, which is equivalent to 11.1% of gross domestic product (GDP); this allocation of fundsmay have contributed to France having the highest life expectancy with age 81. In contrast, the Republic of Congo invested just 42 (USD) per year per person, corresponding to 2.1% of GDP, and the population has a life expectancy of only 54years (WHO 2006, Table1). These investments constitute a limit for health management. Developing countries have a very limited amount of resources to establish efficient and effective health care systems.
Objectives: •achieve efficient cost-effective management. •reward healthcare companies who (a) work toward prevention and reduction of prevalent diseases that generate high costs, and (b) reduce spending generated by the advanced stages of preventable diseases.
Methods:•develop standardized guidelines for the management of diseases with evidence-based scientific rigor and at an acceptable cost. •develop a monitoring system for health care promotion. •develop a method of monitoring insurance companies' and health service institutions' (e.g. hospitals) use of disease prevention and control of risk factors Analyze the results including financial implications to generate internal policies.
Results: Building financial stability for all companies that comply with health prevention policies, delivering a budget increase for those healthcare promoting companies whose load of high-cost patients exceeds the standard deviation and decrease the budget for those who have reduced load.This will reward only those companies who implement an effective intervention and prevention procedure that has reduced the cost of these diseases over time.
Objectives: •achieve efficient cost-effective management. •reward healthcare companies who (a) work toward prevention and reduction of prevalent diseases that generate high costs, and (b) reduce spending generated by the advanced stages of preventable diseases.
Methods:•develop standardized guidelines for the management of diseases with evidence-based scientific rigor and at an acceptable cost. •develop a monitoring system for health care promotion. •develop a method of monitoring insurance companies' and health service institutions' (e.g. hospitals) use of disease prevention and control of risk factors Analyze the results including financial implications to generate internal policies.
Results: Building financial stability for all companies that comply with health prevention policies, delivering a budget increase for those healthcare promoting companies whose load of high-cost patients exceeds the standard deviation and decrease the budget for those who have reduced load.This will reward only those companies who implement an effective intervention and prevention procedure that has reduced the cost of these diseases over time.
Images
